Breast cancer drug, Abraxane effective for lung cancer International Business Times Australia Abraxane, the leading breast cancer drug has been found to be effective in fighting non small cell lung cancer (NSCLC), based on an international study. ...
Kashmiris condole death of India's envoy to Italy India Talkies Khan was suffering from lung cancer for the last eight months. 'Ironically, his younger son is currently doing research on small cell cancer in the US, ...
RxNews Recap for Thursday 03-18-10 BioMedReports (subscription) (blog) ... pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy. ...
Kashmiris condole death of India's envoy to Italy Mangalorean.com Khan was suffering from lung cancer for the last eight months. "Ironically, his younger son is currently doing research on small cell cancer in the US, ...
Kashmiris condole death of India's envoy to Italy South Asia Mail Khan was suffering from lung cancer for the last eight months. Ironically, his younger son is currently doing research on small cell cancer in the US, ...
Novelos Therapeutics Discontinues Current Development Program BioResearch Online (press release) ... pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy. ...
Breast cancer drug fights lung cancer BigPond News An international study has shown the drug Abraxane could be used to fight non small cell lung cancer (NSCLC). The phase-three trial took in just over 1000 ...
Kashmiris condole death of India's envoy to Italy Bombay News Khan was suffering from lung cancer for the last eight months. 'Ironically, his younger son is currently doing research on small cell cancer in the US, ...
EU drugs body backs extended use for OSI's Tarceva Reuters VX) be marketed for first-line maintenance of patients with locally advanced or metastatic non-small-cell lung cancer. Recommendations by the European ...
